ABT Abbott Laboratories

Price (delayed)

$113.95

Market cap

$197.72B

P/E Ratio

34.74

Dividend/share

$2.08

EPS

$3.28

Enterprise value

$205.12B

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott ...

Highlights
Abbott Laboratories's debt has decreased by 12% YoY and by 5% QoQ
ABT's equity is up by 5% year-on-year and by 3% since the previous quarter
Abbott Laboratories's net income has decreased by 17% YoY but it has increased by 11% QoQ
The EPS has contracted by 17% YoY but it has grown by 11% from the previous quarter
The gross profit has declined by 10% year-on-year
The revenue has contracted by 8% YoY

Key stats

What are the main financial stats of ABT
Market
Shares outstanding
1.74B
Market cap
$197.72B
Enterprise value
$205.12B
Valuations
Price to book (P/B)
5.1
Price to sales (P/S)
4.94
EV/EBIT
28.1
EV/EBITDA
19.45
EV/Sales
5.11
Earnings
Revenue
$40.11B
EBIT
$7.3B
EBITDA
$10.54B
Free cash flow
$5.06B
Per share
EPS
$3.28
Free cash flow per share
$2.91
Book value per share
$22.37
Revenue per share
$23.05
TBVPS
$23.4
Balance sheet
Total assets
$73.21B
Total liabilities
$34.39B
Debt
$14.68B
Equity
$38.83B
Working capital
$8.83B
Liquidity
Debt to equity
0.38
Current ratio
1.64
Quick ratio
1
Net debt/EBITDA
0.7
Margins
EBITDA margin
26.3%
Gross margin
55.2%
Net margin
14.3%
Operating margin
16.2%
Efficiency
Return on assets
7.8%
Return on equity
15.1%
Return on invested capital
21.1%
Return on capital employed
12.3%
Return on sales
18.2%
Dividend
Dividend yield
1.83%
DPS
$2.08
Payout ratio
63.4%

ABT stock price

How has the Abbott Laboratories stock price performed over time
Intraday
0.41%
1 week
2.19%
1 month
-5.08%
1 year
17.34%
YTD
3.53%
QTD
3.53%

Financial performance

How have Abbott Laboratories's revenue and profit performed over time
Revenue
$40.11B
Gross profit
$22.13B
Operating income
$6.48B
Net income
$5.72B
Gross margin
55.2%
Net margin
14.3%
The operating income has contracted by 23% YoY but it has grown by 8% from the previous quarter
Abbott Laboratories's net income has decreased by 17% YoY but it has increased by 11% QoQ
Abbott Laboratories's operating margin has decreased by 16% YoY but it has increased by 8% from the previous quarter
Abbott Laboratories's net margin has increased by 11% QoQ but it has decreased by 10% YoY

Growth

What is Abbott Laboratories's growth rate over time

Valuation

What is Abbott Laboratories stock price valuation
P/E
34.74
P/B
5.1
P/S
4.94
EV/EBIT
28.1
EV/EBITDA
19.45
EV/Sales
5.11
The EPS has contracted by 17% YoY but it has grown by 11% from the previous quarter
ABT's P/E is 8% below its 5-year quarterly average of 37.6 but 3.3% above its last 4 quarters average of 33.5
ABT's price to book (P/B) is 6% higher than its last 4 quarters average of 4.8 but 4.3% lower than its 5-year quarterly average of 5.3
ABT's equity is up by 5% year-on-year and by 3% since the previous quarter
ABT's P/S is 9% above its last 4 quarters average of 4.5 and 2.5% above its 5-year quarterly average of 4.8
The revenue has contracted by 8% YoY

Efficiency

How efficient is Abbott Laboratories business performance
ABT's ROE is down by 21% YoY but it is up by 9% from the previous quarter
The ROIC has contracted by 19% YoY but it has grown by 6% from the previous quarter
Abbott Laboratories's return on assets has decreased by 17% YoY but it has increased by 11% QoQ
The ROS has contracted by 10% YoY but it has grown by 6% from the previous quarter

Dividends

What is ABT's dividend history
DPS
$2.08
Dividend yield
1.83%
Payout ratio
63.4%
Recent dividends

Financial health

How did Abbott Laboratories financials performed over time
The total assets is 113% more than the total liabilities
Abbott Laboratories's total liabilities has decreased by 8% YoY
ABT's quick ratio is down by 6% year-on-year and by 3.8% since the previous quarter
Abbott Laboratories's debt is 62% lower than its equity
Abbott Laboratories's debt to equity has decreased by 16% YoY and by 7% from the previous quarter
Abbott Laboratories's debt has decreased by 12% YoY and by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.